MiR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer

Oncogene

Volumn 34, Issue 6, 2015, Pages 717-725

  Wen, S Y ^a,b   Lin, Y ^b   Yu, Y Q ^c   Cao, S J ^d   Zhang, R ^e   Yang, X M ^b   Li, J ^b   Zhang, Y L ^b   Wang, Y H ^b   Ma, M Z ^b   Sun, W W ^d   Lou, X L ^d   Wang, J H ^f   Teng, Y C ^a   Zhang, Z G ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

^d Shanghai Songjiang District Central Hospital   (China)

^e Shanghai Fengxian District Central Hospital   (China)

^f SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLI3 PROTEIN, HUMAN; KI 67 ANTIGEN; KRUPPEL LIKE FACTOR; MICRORNA; MIRN506 MICRORNA, HUMAN; NERVE PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG SCREENING; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; UTERINE CERVICAL NEOPLASMS;

ANIMALS; CELL LINE, TUMOR; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; KI-67 ANTIGEN; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICRORNAS; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84895417812     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.9     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration, Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26: 5802-5812.
3. Ambros V, Lee RC. Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol 2004; 265: 131-158.
4. McManus MT. MicroRNAs and cancer. Sem Cancer Biol 2003; 13: 253-258.
5. Lim YY, Wright JA, Attema JL, Gregory PA, Bert AG, Smith E et al. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci 2013; 126: 2256-2266.
6. Mitra AK, Zillhardt M, Hua Y, Tiwari P, Murmann AE, Peter ME et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov 2012; 2: 1100-1108.
7. Sun MM, Li JF, Guo LL, Xiao HT, Dong L, Wang F et al. TGF-ß1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma. Oncogene 2014; 33: 2075-2086.
8. Roy SS, Gonugunta VK, Bandyopadhyay A, Rao MK, Goodall GJ, Sun L-Z et al. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene 2014; 33: 3707-3716.
9. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005; 37: 766-770.
10. Castro RE, Rodrigues CM. Targeting miR-506 in primary biliary cirrhosis to support the HCO3-umbrella. Clin Res Hepatol Gastroenterol 2012; 36: 402-404.
11. Banales JM, Saez E, Uriz M, Sarvide S, Urribarri AD, Splinter P et al. Up-regulation of microRNA 506 leads to decreased Cl-/HCO3-anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 2012; 56: 687-697.
12. Streicher KL, Zhu W, Lehmann KP, Georgantas RW, Morehouse CA, Brohawn P et al. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. Oncogene 2011; 31: 1558-1570.
13. Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM, Xiao SD et al. MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett 2011; 585: 3560-3568.
14. Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot Chad V et al. Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer. Cancer Cell 2013; 23: 186-199.
15. Zhao Y, Liu H, Li Y, Wu J, Greenlee AR, Yang C et al. The role of miR-506 in transformed 16HBE cells induced by anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide. Toxicol Lett 2011; 205: 320-326.
16. Kang HN, Oh SC, Kim JS, Yoo YA. Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53. Exp Cell Res 2012; 318: 539-549.
17. Steg A, Amm HM, Novak Z, Frost AR, Johnson MR. Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer. Cancer Biol Ther 2010; 10: 893-902.
18. Kim KH, Kim JM, Choi Y-L, Shin YK, Lee H-c, Seong IO et al. Expression of Sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium. Pathol Int 2009; 59: 279-287.
19. Liu K, Zhao H, Yao H, Lei S, Lei Z, Li T et al. MicroRNA-124 regulates the proliferation of colorectal cancer cells by targeting iASPP. Biomed Res Int 2013; 2013: 1-10.
20. Wang P, Chen L, Zhang J, Chen H, Fan J, Wang K et al. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene 2013; 33: 514-524.
21. Furuta M, Kozaki Ki, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2009; 31: 766-776.
22. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6: 14.
23. Pierson J, Hostager B, Fan R, Vibhakar R. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 2008; 90: 1-7.
24. Li KKW, Pang JC-s, Ching AK-k, Wong CK, Kong X, Wang Y et al. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 2009; 40: 1234-1243.
25. Shi XB, Xue L, Ma AH, Tepper CG, Gandour-Edwards R, Kung HJ et al. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene 2012; 32: 4130-4138.
26. Wilting SM, van Boerdonk RAA, Henken FE, Meijer CJLM, Diosdado B, Meijer GA et al. Methylation-mediated silencing and tumour suppressive function of hsamiR-124 in cervical cancer. Mol Cancer 2010; 9: 167.
27. Renault MA, Roncalli J, Tongers J, Misener S, Thorne T, Jujo K et al. The hedgehog transcription factor gli3 modulates angiogenesis. Circ Res 2009; 105: 818-826.
28. Sengupta A, Banerjee D, Chandra S, Banerji SK, Ghosh R, Roy R et al. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 2007; 21: 949-955.
29. Iwasaki H, Nakano K, Shinkai K, Kunisawa Y, Hirahashi M, Oda Y et al. Hedgehog Gli3 activator signal augments tumorigenicity of colorectal cancer via upregulation of adherence-related genes. Cancer Sci 2013; 104: 328-336.
30. Renault MA, Roncalli J, Tongers J, Misener S, Thorne T, Jujo K et al. The hedgehog transcription factor Gli3 modulates angiogenesis. Circ Res 2009; 105: 818-826.
31. Scherr M, Venturini L, Battmer K, Schaller-Schoenitz M, Schaefer D, Dallmann I et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res 2007; 35: e149-e149.
32. Kutner RH, Zhang X-Y, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protocols 2009; 4: 495-505.
33. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134.